Pronađeno: 1-4 / 4 radova

Autori: Reusch Michael

>> Prikaži sve rezultate

Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article)
Autori Barratt Jonathan  Dellanna Frank  Portoles Jose  Choukroun Gabriel  De Nicola Luca  Young James  Dimkovic Nada B  Reusch Michael 
Info ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559
Projekat Astellas Pharma, Inc.; Astellas Pharma, Inc. [DOLOMITES: NCT02021318]; FibroGen, Inc. [SIERRAS: NCT02273726, HIMALAYAS: NCT02052310]; AstraZeneca [ROCKIES: NCT02174731]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article)
Autori Barratt Jonathan  Dellanna Frank  Portoles Jose  Choukroun Gabriel  De Nicola Luca  Young James  Dimkovic Nada B  Reusch Michael 
Info ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559
Projekat Astellas Pharma, Inc. (DOLOMITES); FibroGen, Inc.; AstraZeneca; [NCT02021318]; [NCT02273726]; [NCT02052310]; [NCT02174731]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS) (Article)
Autori Shutov Evgeny  Sulowicz Wladyslaw  Esposito Ciro  Tataradze Avtandil  Andric Branislav R  Reusch Michael  Valluri Udaya  Dimkovic Nada B 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021), vol. 36 br. 9, str. 1629-1639
Projekat Astellas Pharma, Inc.Astellas Pharmaceuticals
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES) (Article)
Autori Barratt Jonathan  Andric Branislav R  Tataradze Avtandil  Schoemig Michael  Reusch Michael  Valluri Udaya  Mariat Christophe 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021), vol. 36 br. 9, str. 1616-1628
Projekat Astellas Pharma, Inc.Astellas Pharmaceuticals
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX